Quinazolinone derivatives and their use as B-Raf inhibitors

Details for Australian Patent Application No. 2005278961 (hide)

Owner AstraZeneca AB

Inventors Lyne, Paul; Pontz, Timothy; Aquila, Brian

Agent Davies Collison Cave

Pub. Number AU-A-2005278961

PCT Pub. Number WO2006/024836

Priority 60/606,535 01.09.04 US

Filing date 26 August 2005

Wipo publication date 9 March 2006

International Classifications

C07D 239/90 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/024836 Priority application(s): WO2006/024836

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005278962-Isoindolin-1-one derivatives

2005278959-Quinazolinone derivatives and their use as B-Raf inhibitors